This excellence preclinical research network is dedicated to microbiome and infectious diseases research field and offers synergic expertise and large customized services in high-throughput sequencing, biomanufacturing, imaging, microfluidics, specific analyses, biomarkers, preclinical and clinical activities.
Virnext brings to the Cynbiome® network its expertise in emergent and re-emergent respiratory viruses and provides a large panel of in vitro and in vivo preclinical models of infections dedicated to the screening and evaluation of of prophylactic and therapeutic candidates in BSL-2 and BSL-3 in-house facilities.
Led by Cynbiose, a CRO specialized in preclinical reserach services with a core focus on NHP models, the public-private network Cynbiome® is supported by the French government, BpiFrance and the Région Auvergne-Rhône-Alpes.
Active biomarkers Bioaster Biofortis Biose Carmen Ciri Cynbiose Hawkcell Lyonbiopole Maat Pharma Netri SFRbioscience Virnext Viroscan 3D VirPath
